Generic Name
Zafirlukast
FDA approval date: November 18, 2010
Classification: Leukotriene Receptor Antagonist
Form: Tablet
What is Zafirlukast?
Zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older.
Approved To Treat
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment